The EU Paediatric Regulation: The Way Forward or a Bottleneck to Progress for the Pharma Industry?
This article was originally published in SRA
Executive Summary
We would like to clarify a number of points regarding the comments made in the May 2009 issue of RAJ Pharma by Brian Ager, the director general of the European Federation of Pharmaceutical Industries and Associations, EFPIA, on the implementation of the Paediatric Regulation1,2.